Navigation Links
Matrix Laboratories Completes Name Change to Mylan Laboratories
Date:10/19/2011

PITTSBURGH and HYDERABAD, India, Oct. 19, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its India-based subsidiary, Matrix Laboratories Limited, has formally changed its name to Mylan Laboratories Limited. The name change is effective immediately. Mylan announced its intention to rebrand Matrix as a Mylan company earlier this year.

Mylan Inc. Chairman and CEO Robert J. Coury said: "We are pleased to complete the name change from Matrix to a Mylan company and are excited to operate in India under one powerful brand. For the last 50 years, the Mylan name has stood for high quality products, unmatched reliability, outstanding customer service, unrelenting integrity, continuous innovation and serving unmet needs. Mylan's unwavering commitment to quality and long-standing track record of excellence set us apart from our competitors and will help to ensure our long-term success in India and around the world. We look forward to further educating customers, physicians, pharmacists and patients about the Mylan brand as we continue to grow our existing business and launch in the Indian commercial market in the coming months."

The name change has been approved by the Registrar of Companies in India. Mylan intends to retain the Matrix name for its institutional ARV franchise.

About Mylan Laboratories Limited
Mylan Laboratories Limited, founded as Matrix Laboratories Limited in 2001 in Hyderabad, India, is one of the world's largest manufacturers of low cost, high quality active pharmaceutical ingredients (API). Today, the company has a wide range of products, including those in the anti-asthmatic, antibacterial, antifungal, antiretroviral (ARV), cardiovascular, CNS, gastrointestinal and pain management segments. Mylan Laboratories also offers a growing line of finished dosage form products, predominantly generic ARV therapies for the treatment of HIV/AIDS, including both adult and pediatric therapies.  

About Mylan Inc.
Mylan Inc., headquartered in Pittsburgh, Pa., ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
2. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
3. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
4. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
5. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
6. Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
7. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
8. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
9. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
10. Dr. Julian Henley MD Presents BioMatrix Lift
11. NeoMatrix, Inc., Awarded New Technology Agreement by Novation for HALO(R) Breast Pap Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is ... of mind and move the readers one step closer to God. “Psalms of Humidity” ... that his mistakes that have been made within his life are the very same ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... jiu-jitsu community have raised more than $15,000 in just a couple of weeks ... submission grappling matches and world-class instructor seminars, organizers expect to double those initial ...
(Date:9/19/2017)... ... 2017 , ... Peter Chandonait, Abt Associates Principal Scientist and ... Africa Indoor Residual Spraying (AIRS) Project , has been named the Grand Prize ... Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners who have ...
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... RESTON, Va (PRWEB) , ... September 19, 2017 , ... ... on the use of health IT to create efficiencies in healthcare information exchange and ... announced the release of their latest industry white paper, entitled Barriers to Adoption ...
Breaking Medicine News(10 mins):